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In the cystic fibrosis (CF) airway, chronic infection by Pseudomonas aeruginosa results from
biofilm formation in a neutrophil-rich environment. We tested the capacity of human neutrophils to
modify early biofilm formation of P. aeruginosa strain PAO1, and an isogenic CF strain isolated
early and years later in infection. In a static reactor, P. aeruginosa biofilm density of all strains was
enhanced at 24 h in the presence of neutrophils, with the greatest relative increase associated
with the lowest inoculum of P. aeruginosa tested. Previously, neutrophil-induced biofilm
enhancement was shown to largely result from the incorporation of F-actin and DNA polymers into
the bacterial biofilm. This finding was advanced by the comparison of biofilm enhancement from
intact unstimulated neutrophils and from lysed or apoptotic neutrophils. Apoptotic neutrophils,
with an intact cell membrane, were unable to contribute to biofilm enhancement, while lysed
neutrophils evoked a similar response to that of intact cells. Using F-actin and DNA as targets, the
capacity of negatively charged poly(amino acids) to disrupt, or prevent, early biofilm formation was
tested. Anionic poly(aspartic acid) effectively prevented or disrupted biofilm formation.
Combination of poly(aspartic acid) with DNase resulted in a synergistic increase in biofilm
disruption. These results demonstrate that the presence of dying neutrophils can facilitate the
initial stages of biofilm development by low inocula of P. aeruginosa. Neutrophil F-actin represents
a potential new therapeutic target for disruption of pathogenic biofilms.
INTRODUCTION
Cystic fibrosis (CF) lung disease features persistent neutro-
phil accumulation within the airways from the time of
infancy (Khan et al., 1995). Inhalation of aerosolized
Pseudomonas aeruginosa occurs frequently from envir-
onmental exposures, including dirt and contaminated water
(Baumgartner & Grand, 2006; Burns et al.,2 0 0 1 ;K h a net al.,
2007). While eradication of P. aeruginosa is possible in
childhood, persistent infection eventually occurs in over
80% of adult CF patients. Chronic P. aeruginosa infection is
clearly linked with increased morbidity and mortality in CF
(Emerson et al., 2002; Parad et al., 1999; Schaedel et al.,
2002), and is associated with phenotypic and genetic changes
of the bacteria within the airway, including the formation of
biofilms (Drenkard & Ausubel, 2002; Ernst et al.,1 9 9 9 ;
Spencer et al., 2003). In classical models, bacterial biofilms
are surface-attached communities of cells encased within a
self-produced extracellular polysaccharide matrix, often
associated with mucoidy (Costerton et al., 1999; Klausen et
al., 2003). However, biofilms in the CF airway are not
typicallysurface-associated,but ratherare smallaggregatesof
bacteriasuspendedinthehighlytenacious CF sputum(Singh
et al., 2000; Sriramulu et al., 2005).
Persistent accumulation of neutrophils in the CF airways,
combined with ineffective clearance, leads to the unco-
ordinated release of DNA, actin and granule proteins from
necrotic cells. This process results in mucus highly enriched
with these products, all of which are clearly implicated in
the pathogenesis of CF lung disease (Balfour-Lynn, 1999;
Khan et al., 1995; Lethem et al., 1990; Perks & Shute, 2000;
Roum et al., 1993; Sheils et al., 1996). Previously, we have
reported that the level of early biofilm formation by P.
aeruginosa strain PAO1 is increased in the presence of
neutrophils (Walker et al., 2005). A principal mechanism
Abbreviations: CF, cystic fibrosis; CV, crystal violet; SEM, scanning
electron microscopy.
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DNA and F-actin, which provide a ready framework for P.
aeruginosa biofilm development (Walker et al., 2005).
The F-actin and DNA framework formed following neutro-
phil necrosis is an attractive potential target for therapeutic
intervention, as disrupting this scaffold could limit or
decrease the integrity of an early P. aeruginosa biofilm.
Negatively charged strands of DNA when present with
F-actin are linked via positively charged histones and
cations (Tang et al., 2005). Recently it has been shown that
polyanionic peptides have the capacity to disassociate
DNA–histone, as well as F-actin–histone complexes, and
disaggregate F-actin bundles (Tang & Janmey, 1996; Tang
et al., 2005). These findings suggest that a DNA-based
biofilm that has incorporated F-actin could be disrupted by
anionic polymers via electrostatic competition. Further, the
addition of these anionic polymers could cooperatively
enhance the activity of current therapies such as DNase.
METHODS
Bacterial strains, media and culture conditions. All P. aeruginosa
strains were originated from stock plates of Luria broth (LB) agar,
grown overnight in RPMI 1640 supplemented with L-glutamine and
2% heat-inactivated (human) platelet-poor plasma (HIPPP) at 37 uC
with moderate shaking (225 r.p.m.) overnight, and frozen down to
achieve consistent growth phase. All assays utilized bacteria grown
overnight from the frozen stock in RPMI+2% HIPPP at 37uC.
Cultures were then equilibrated in a Beckman DU 640 spectropho-
tometer to an OD650 of 0.30 (5610
8 c.f.u. ml
21). Serial 10-fold
dilutions of the cultures were performed in RPMI. Strains utilized were
PAO1 (from B. H. Iglewski, University of Rochester, New York, USA)
and an early and late strain isolated from a single patient days after
initial infection, and following years of infection (Ogle et al.,1 9 8 7 ) .
Neutrophil isolation. Neutrophils for all assays were isolated from
healthy volunteers by the plasma Percoll method as previously
described (Haslett et al., 1985).
Crystal violet (CV) biofilm assay. Donor neutrophils were
resuspended at a concentration of 16.6610
6 cells ml
21 in RPMI+
2% HIPPP in a Nunc round-bottom 96-well plate. The cellular control
was a plate identical tothe test plate, save for the absence ofneutrophils.
Dilutions of bacteria were tested at a 1:1 ratio to a 1:0.001 ratio, thus
final concentrations of bacteria ranged from 16.6610
6 to 16.6610
3
c.f.u. ml
21. A Nunc TSP lid system, which comprises a 96-well plate lid
with pegs that extend into each well, was then placed on a 96-well plate.
This assembly was then incubated for 24 h with rocking (3–4
oscillations min
21)a t3 7 uC. At 24 h, the peg lids with bacterial
biofilms were removed and rinsed for 2 min in sterile normal saline to
remove non-adherent bacteria and cellular debris. The peg lid was air-
dried for 5 min, then fixed for 10 min in 100% ethanol. The ethanol
was evaporated for 5 min on the bench top, then biofilms were stained
in 1% CV for 15 min. Excess CV was removed by two rinses in normal
saline. Decolorization took place in a Nunc 96-well flat-bottom plate
with200 ml100%methanolperwellfor45 min.Readingsweretakenin
a mQuant plate reader using the KCjunior v1.403 software at 550 nM
(BioTek Instruments). Values within control samples were averaged
prior to comparison of each test well.
Amino acid preparation. Pure amino acid chains of multiple
lengths were initially diluted in PCR grade dH2O to 1 M, then serially
diluted in normal saline. Peptides used were poly(L-aspartic acid)
(Sigma) and poly(serine) (MP Biomedicals). No further purification
was performed. Pulmozyme (DNase) (Genetech; NDC 50242-0100-
40) was added at final concentrations of 33 mg DNase ml
21 or 8.25 mg
DNase ml
21. Protease inhibitors were used at final concentrations of
2.56 mg leupeptin ml
21, 1.03 mg pepstatin A ml
21 and 2.56 mg
aprotinin ml
21.
Quantification of viable bacteria within biofilm. To quantify the
density of biofilms formed under various conditions, biofilms were
established on a Nunc TSP plate lid as described above. Pegs were
rinsed in saline for 2 min, then placed in a 96-well round-bottom
Nunc plate with 150 ml sterile saline and sonicated twice for 10 min in
a Fisher FS 110 sonicator. Test wells were pooled and serially diluted
for quantification by colony counts.
An alternative method was utilized to compare bacterial quantity by
c.f.u. to quantification by metabolism via alamarBlue reduction. First,
biofilms were established on a Nunc TSP 96-well plate lid as described
above with 2.5610
4 bacteria (PMN to bacteria ratio of 1:0.01). Pegs
were rinsed in saline for 2 min, then the lid was divided in half. Half
the lid was treated with a combination of DNase and poly(L-aspartic
acid) at concentrations of 66 mg DNase ml
21 and 5 mM, respectively,
for 20 min. Following digestion, the contents of wells were removed,
serially diluted in saline, and plated on LB agar. The treated and
untreated lid halves were then placed into alamarBlue development
medium (200 ml total well volume, comprising 130 ml RPMI 1640x,
50 ml2 6 LB broth and 20 ml alamarBlue (Invitrogen) in a Costar
3603 well plate (Corning). Plates were read in a FLX 800 plate reader
(BioTek instruments) every half hour for 24 h at 37 uC with shaking.
Bacterial counts were derived from plotting the V50 of sample wells
calculated by a Boltzmann sigmoidal non-linear regression against the
V50 of standard curves generated by defined concentrations of
bacteria that were plotted in a linear regression against log c.f.u.
Neutrophil lysis and induction of apoptosis to induce biofilm
growth. To examine the role of available cellular constituents as well
as living neutrophils in P. aeruginosa biofilm enhancement, we
compared biofilm density in the presence of intact unstimulated
neutrophils to that in the presence of lysed or apoptotic neutrophils.
Lysed neutrophils were prepared the same way as living neutrophils,
but were frozen and thawed (280 uC for 15 min) once prior to
addition of bacteria. Apoptosis was induced by suspending neutro-
phils at 2.0610
6 cells ml
21 in apoptosis buffer (137 mM NaCl,
2.7 mM KCl, 2 mM MgCl2, 5 mM glucose, 10 mM HEPES pH 7.4,
0.05% delipidated BSA) and UV irradiation (254 nm) on a Fotodyne
3-3000 UV transilluminator for 5 min. Cells were then incubated at
37 uC with shaking (30 r.p.m.) in conical polypropylene tubes.
Apoptosis was determined using an aliquot of 2610
5 cells which were
diluted and cytocentrifuged at 600 r.p.m. for 2 min on glass slides
and stained with a modified Wright–Giemsa stain. Cells were counted
as apoptotic if their nuclei lost segmentation and appeared round and
darkly stained as described previously (Whitlock et al., 2000). At least
200 cells were counted per slide in a blinded fashion until .80%
apoptosis had been reached. Biofilms were grown for 24 h after the
addition of bacteria, then assessed by CV staining as detailed above.
Light microscopy. Intact, lysed and apoptotic neutrophils were
prepared as described above and P. aeruginosa strain PAO1 was added
at a concentration ratio of 1:0.01 in an 18-well slide (total volume of
20 ml) (Ibidi). Slides were incubated at 37 uC for 30 min, then fixed
with 1.3% glutaraldehyde+33.3% ethanol at room temperature for
5 min. Fixative was removed and the slide was stained with a
modified Wright–Giemsa stain. Slides were visualized on bright-field
with an Axiovert 200M microscope (Carl Zeiss) using a 663 oil
objective. Images were minimally level adjusted using Adobe
Photoshop CS to show detail.
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isolates (2.5610
4 c.f.u.) were grown in the presence or absence of
neutrophils (2.5610
6) (PMN to bacteria ratio of 1:0.01) for 48 h.
Pegs were rinsed briefly with 0.9% saline to remove non-biofilm-
associated mass and were fixed with 2.5% glutaraldehyde in 0.1 M
cacodylate buffer (pH 7.2) at 4 uC for 20 h. The pegs were then
washed in 0.1 M cacodylate buffer for 10 min, and rinsed in ddH2O
briefly. The pegs were then dehydrated in 70% ethanol for 15 min.
Pegs were air-dried for a minimum of 72 h, removed from the TSP
reactor with a hot scalpel, and affixed to carbon stubs with epoxy
resin and allowed to dry. Following gold sputter coating, SEM was
performed using a JEOL 5800LV scanning electron microscope at low
and high magnifications to visualize both gross as well as fine detail.
Images were contrast/brightness-adjusted in Adobe Photoshop CS. All
images of biofilms grown without neutrophils had a despeckle filter
minimally applied to reduce background.
Verification of isogenic status of early and late CF P.
aeruginosa isolates. In order to confirm the lineage of the strains
utilized in this report, a series of PCRs were run that amplify variable
number tandem repeats (Onteniente et al., 2003). Briefly, this method
amplifies tandem repeats of nucleotides of defined size that occur in
variable number, which is related to lineage of the bacteria. Thus
products of similar sizes indicate a closer lineage. Reaction conditions
and primers were as described by Onteniente et al. (2003). Taq
polymerase was Eppendorf MasterMix. Primers were purchased from
IDT.
This assay resulted in seven of eight primers providing a product, and
all of the reaction products of the early and late strains were identical
(see Supplementary Fig. S1 in JMM Online). In all reactions, the CF
early and late strains produced products of an identical size. Neither
clinical strain produced a product from primer set 5915, indicating
that this particular variable number tandem repeat was not present;
however, a product was produced by PAO1 (Supplementary Fig.
S1d). PAO1 produced differently sized products from the CF strain in
all primer sets save 3496. Coupled with previously published pulse-
field data (Ogle et al., 1987), we are satisfied that these strains
represent isogenic bacteria that have been isolated both at initial
colonization (environmental) as well as after prolonged infection
from a child with CF (host-adapted).
Statistical analysis. Data were analysed using Prism 4 (Graphpad
version 4.03) or Excel (Microsoft Office 2003). Student’s t-test was
used to determine significance of paired data. One-way, and repeated
measures ANOVA were performed on data where multiple testing
resulted in datasets that required additional post-test analysis. Tukey’s
post test, where all datasets are compared to each other, and
Dunnett’s post test, where multiple datasets are compared to a single
control set, were utilized as noted, with significance at a value no less
than P ,0.05.
RESULTS AND DISCUSSION
P. aeruginosa biofilm density and quantity of
associated bacteria are increased by the presence
of human neutrophils
Human neutrophils isolated from healthy volunteers were
combined with P. aeruginosa strain PAO1 (Fig. 1a), an
early CF isolate (Fig. 1b) and an isogenic late CF isolate
(Fig. 1c) over a range of bacteria to neutrophil ratios
spanning 4 logs. All ratios of bacteria to neutrophils tested
resulted in a significant (P ,0.05) enhancement of biofilm
density when compared to P. aeruginosa of equal concen-
tration grown in the absence of neutrophils, as measured
by CV staining. To verify that neutrophil-induced increases
in biofilm density also result in an increase in the bacterial
population, we examined the metabolism of the biofilm
with an alamarBlue reduction viability assay, and com-
pared the results to biofilm density as quantified by CV
staining. A similar pattern of neutrophil-induced biofilm
enhancement was found to exist between methods (Supple-
mentary Fig. S2). Further, bacterial counts calculated by
alamarBlue assay were determined to be similar to those
when biofilms were digested and plated (data not shown).
In sum, these results indicate that the presence of human
neutrophils enhances early biofilm density and quantity of
Fig. 1. P. aeruginosa biofilm formation is enhanced by human neutrophils. Biofilm density following 24 h of bacterial growth in
the presence (open bars) or absence (black bars) of neutrophils. At time 0, a fixed inoculum of neutrophils (2.510
6) was
combined with P. aeruginosa at a 1:1 ratio, and decreasing 10-fold concentrations of bacteria to 1:0.001. Strains examined
were PAO1 (a), a clinical CF strain isolated early after initial infection (b) and an isogenic mucoid strain isolated from the same
patient 4 years later (c). Biofilm formation was quantified by CV staining, with correlated absorbance presented on a log10 scale.
Significance of the addition of neutrophils (*) was calculated by Student’s t-test at P ,0.05, with comparisons as noted. The
results represent the means of 10 independent experiments.
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aeruginosa biofilms from PAO1 as well as isogenic early
and late CF isolates by orders of magnitude over that
produced by the bacteria alone at 24 h.
Though intrinsically capable of forming biofilms, in the
absence of neutrophils, decreasing initial concentrations of
P. aeruginosa (inocula ranging from 2.5610
6 to 2.5610
3
c.f.u.) resulted in a significant decrease in biofilm density
from each concentration to the next, save the two most
dilute samples (Fig. 1a–c). Under the conditions tested, a
basal level of biofilm formation is reached at an inoculum
of 2.5610
4 c.f.u. and decreasing the bacterial concentra-
tion further has no effect in decreasing uninduced biofilm
density. This is of particular interest, as the initial
inoculum of P. aeruginosa entering the CF airway is likely
quite small.
Neutrophils are short-lived cells, and in the presence of
P. aeruginosa rapidly progress to death via necrosis or
apoptosis. Necrotic cell death features loss of cell mem-
brane integrity and the uncoordinated release of nuclear
and cytoplasmic contents. Programmed cell death via
apoptosis proceeds through a coordinated series of steps,
which results in nuclear fragmentation and intense
chromatin condensation, but maintenance of a near-to-
intact cytoplasmic membrane. We compared the level of
biofilm induction resultant from combining bacteria with
intact viable cells to that with lysed or apoptotic neutro-
phils. Within 30 min, many of the intact neutrophils had
undergone lysis, and bacteria were seen to aggregate in the
presence of necrotic debris (Fig. 2b). A similar effect was
seen following 30 min of co-incubation with lysed neutro-
phils (Fig. 2c). In contrast, neutrophils induced to apopto-
sis prior to exposure to P. aeruginosa remained intact, and
the bacteria remained dispersed (Fig. 2d). By 24 h, viable
and lysed neutrophils induced equivalent levels of biofilm
enhancement, but apoptotic neutrophils induced signifi-
cantly less when compared to the live PMNs (P ,0.001)
(Fig. 2e). Together, these results demonstrate that apopto-
tic death of the neutrophil limits the availability of F-actin
and DNA, which is required to enhance early P. aeruginosa
biofilm formation. It is widely accepted that neutrophil
apoptosis represents a beneficial response in reducing
tissue injury from uncoordinated release of various cyto-
toxic components of the leukocyte. Our findings support
the idea that in the presence of P. aeruginosa, neutrophil
apoptosis also serves to limit the capacity of the pathogen
to form a biofilm.
Biofilms of P. aeruginosa strain PAO1 (Fig. 3; Supple-
mentary Fig. S3) as well as of the early and late CF strains
(Supplementary Figs S4 and S5) were allowed to form in the
presence of neutrophils, and compared by SEM to biofilms
grown in the absence of neutrophils. The presence of
neutrophils evoked clear differences. Neutrophil-induced
biofilms largely covered each peg, while in the absence of
neutrophils, only scattered aggregates of bacteria were
visualized (Fig. 3; Supplementary Figs S3–S5). In addition,
the architecture of the biofilm was dramatically thicker and
more developed in the presence of neutrophils. Generally, all
three strains followed similar patterns in uninduced and
neutrophil-induced biofilm formation at 48 h.
Fig. 2. P. aeruginosa responds differently to intact, lysed or
apoptotic neutrophils. Intact and unstimulated neutrophils (a) were
incubated with PAO1 (b), and compared to lysed (c) or apoptotic
(d) neutrophils. Biofilms of PAO1 formed in the presence of these
stages of neutrophil death show that intact neutrophils induce
greatest biofilm enhancement, whereas apoptotic neutrophils do
not enhance biofilm development (e). Microscopic examination
(63) of the localization of P. aeruginosa to these neutrophil types
after a half-hour exposure shows that Pseudomonas preferentially
associates with neutrophilic cellular products [necrotizing intact
neutrophils (b) and neutrophil lysate (c)] contrasted to apoptotic
neutrophils (d). Significance (*) was calculated by one-way
ANOVA followed by Tukey’s post-test at P ,0.001. Photomicro-
graphs and graph are representative of four independent experi-
ments; bar, 10 mm.
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biofilms by anionic but not uncharged poly(amino
acids)
Previously, we have shown that polymers of F-actin and
DNA are neutrophil products that enhance biofilm forma-
tion (Walker et al., 2005). Enhancement of P. aeruginosa
biofilm development in the presence of neutrophils was
lost in the presence of DNase, which enzymically
depolymerizes DNA, and gelsolin, which severs F-actin
into small fragments (Walker et al., 2005). Recently it has
been reported that anionic poly(amino acids) can dissolve
negatively charged F-actin and DNA bundles that are
electrostatically associated via positively charged histones
and other multivalent cations (Tang et al., 2005).
Poly(aspartic acid) has a concentrated negative charge that
has a twofold effect. Firstly, it sequesters the histone from
the DNA and F-actin preventing it from serving as a charge
linker between these two polymers (Tang et al., 2005).
Secondly, its acidic nature causes depolymerization of
F-actin to G-actin (Tang & Janmey, 1996). We hypothesize
that these actions could dismantle the early biofilm struc-
ture, as well as prevent initial formation or reformation
after dissolution.
Peptides of equivalent length (median length of 74-mer)
were compared for their capacity to disrupt a 24-h-old
biofilm of P. aeruginosa formed in the presence of human
neutrophils. Homopeptide chains of anionic (Asp)74 and a
polar but uncharged (Ser)74 were analysed. When the 24 h
biofilms were combined with these poly(amino acids)
suspended in saline (free of neutrophil products not
incorporated in the biofilm) for 3 h, a significant
concentration-related disruption of biofilms occurred in
response to (Asp)74 (Fig. 4a). The effect of the anionic
peptide is dose-related, as there was a significant decrease
in biofilm density as the concentration of (Asp)74 was
increased from 5 to 10 mM (Fig. 4a). The polar but
uncharged (Ser)74 did not cause disruption of the biofilm
at either concentration (Fig. 4a).
Effect of poly(amino acid) chain length on biofilm
disruption
To establish whether or not the biofilm-disrupting effect of
negatively charged peptides is related to the length of the
polymer chain, we compared the effect of longer charged
polypeptides. Using equimolar concentrations, amino acid
chains of 260 residues were compared to the 74-mer
polypeptides to determine the effect of chain length on
biofilm disruption. Under these conditions, (Asp)260 was
more effective than (Asp)74 (Fig. 4b).
Proteases reduce the capacity of charged
poly(amino acids) to disrupt neutrophil-induced
P. aeruginosa biofilms
When poly(amino acids) were added directly to the milieu
of necrotic neutrophils in which the biofilm was formed,
the capacity of poly(amino acids) to disrupt biofilms was
diminished (Fig. 5a) compared to reactions conducted in
saline (Fig. 4). Under these conditions, neither (Asp)74
nor (Ser)74 was able to disrupt biofilms. Further, a similar
effect was observed when the long-chain and short-chain
poly(aspartic acid) were compared (Fig. 5b). As both
neutrophils and P. aeruginosa contain and/or synthesize an
array of proteases, which degrade peptide chains, we tested
the capacity of a protease inhibitor cocktail to restore the
potential of poly(amino acids) to disrupt the biofilm under
Fig. 3. SEM of neutrophil-induced enhancement of biofilm density
and architecture. Biofilms of strain PAO1 were grown for 48 h in the
presence or absence of human neutrophils. Examination by SEM at
high magnification demonstrated that biofilms grown without human
neutrophils were scattered sparsely on the reactor pegs (a), while
biofilms grown with neutrophils (b) were much thicker and nearly
confluent. Biofilms grown in thepresenceofhuman neutrophils have
a more established architecture compared to biofilms grown in the
absence of neutrophils. Bar, 8 mm. Photomicrographs are repres-
entative of three independent experiments.
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(Asp)260 significantly disrupted the biofilm compared to
the untreated control (Fig. 5c). With a sevenfold greater
concentration of protease inhibitors, there exists an even
greater restoration of the ability of (Asp)260 to disrupt
biofilms, the reduction in biofilm density increasing from
25% to 52% (Fig. 5c). When the biofilms were removed
from the overnight culture material containing the pro-
ducts of necrotic neutrophils (such as proteases of bacterial
and neutrophil origin), and washed once in saline, addition
of (Asp)260 exhibited a significant disruptive effect, with no
additional enhancement achieved by the addition of the
protease inhibitor cocktail (Fig. 5d). These data support
the conclusion that an anionic polypeptide can disrupt
P. aeruginosa biofilms formed in the presence of human
neutrophils, but proteolytic degradation, likely mediated
by both bacteria and neutrophils, is a significant, though
potentially solvable, obstacle to the use of poly(amino
acids) in a neutrophil-rich environment.
Proteases in the lung environment are known to destroy a
number of host defence mechanisms (Elkington et al.,
2005; Roghanian et al., 2006), and the same seems to apply
to poly(amino acids) in this system. A wide variety of
modifications are now known that protect peptides from
proteases, such as using D isomers or interspersing aspartic
acid residues with non-naturally occurring amino acids.
Studies by our group are under way to both protect the
poly(aspartic acid) chain as well as to identify negatively
charged polymers with greater intrinsic resistance to
proteolytic degradation.
Ciprofloxacin and tobramycin are incapable of
disrupting neutrophil-induced biofilms
Currently, the standard treatment for P. aeruginosa is
antibiotics such as ciprofloxacin or tobramycin, although
treatment with DNase has also been associated with decreased
P. aeruginosa infectious load in the CF airway (Frederiksen et
al., 2006; Gibson et al., 2003). In order to compare the relative
effectiveness of polypeptides in dispersing P. aeruginosa
biofilm in this system, we tested the ability of clinically
relevant antibiotics to disrupt a biofilm induced by human
neutrophils. P. aeruginosa biofilms (24-h-old) were exposed
to twofold dilutions of either ciprofloxacin (Fig. 6a) or
tobramycin (Fig. 6b) in clinically relevant concentrations
ranging from 8 mga n t i b i o t i cm l
21 to 1024 mg antibiotic
ml
21. The biofilm MIC was determined to be 128 mg
antibiotic ml
21 and 256 mga n t i b i o t i cm l
21 for ciprofloxacin
and tobramycin, respectively, under these conditions (data
not shown). The biofilms were exposed for 3 h to antibiotics
then quantified as described above with CV. Even under the
highest concentration, the antibiotics tested demonstrated no
capacity to disrupt the neutrophil-induced P. aeruginosa
biofilm (Fig. 6), consistent with the well-established principle
that conventional antibiotics are relatively less effective
against biofilms (Costerton et al., 1987; Hoyle & Costerton,
1991; Prosser et al., 1987). Azithromycin, an antibiotic
ineffective against planktonic P. aeruginosa, has been shown
to have an antimicrobial effect against P. aeruginosa biofilms
(Moskowitz et al., 2004), to retard biofilm development
(Gillis & Iglewski, 2004), and to block quorum sensing and
alginate polymer formation (Hoffmann et al., 2007). While
azithromycin has not been shown to disrupt an established P.
aeruginosa biofilminvitro(Gillis & Iglewski, 2004), additional
studies are warranted to fully define the anti-biofilm
properties of this agent.
Anionic poly(amino acid) chains have the capacity
to prevent P. aeruginosa biofilm formation
Although treatment of established P. aeruginosa biofilms
likely represents the most relevant clinical scenario, in
certain situations, biofilm formation is a highly predictable
event. If agents existed that were effective in preventing the
formation of the biofilm, strategies could be employed to
reduce the potential for biofilm formation. We tested the
capacity of (Asp)74 or (Ser)74 to inhibit biofilm develop-
ment when added directly to a suspension of P. aeruginosa
and neutrophils (Fig. 7). Biofilm development was quanti-
fied after 24 h incubation as detailed above. Uncharged
(Ser)74 demonstrated no capacity to prevent biofilm
formation, while (Asp)74 was significantly effective at
preventing the formation of biofilms.
The robust activity of this amino acid chain, (Asp)74, in the
prevention of biofilm formation led to the question of an
alternative mechanism of disruption in this system. To
address this, the toxicity or growth-enhancing effect of all
the components used in the peptide assays was tested
individually with P. aeruginosa and, when appropriate, in
Fig. 4. P. aeruginosa biofilms induced by neutrophils are
disrupted by electrostatically charged amino acid chains. (a) P.
aeruginosa (strain PAO1) biofilms formed for 24 h in the presence
of neutrophils were washed in saline and combined with
poly(amino acids) of differing length and charge for 3 h at
37 6C. (Asp)74 at 5 mM (open bars) exhibited disruption of the
biofilm; this effect was significantly greater at 10 mM (black bars).
The uncharged (Ser)74 had no effect. (b) Using poly(amino acids)
at a concentration of 5 mM, the longer (Asp)260 was more effective
than the shorter (Asp)74. All assays are as measured by
absorbance from CV staining. Significance (*) was calculated by
one-way ANOVA followed by Dunnett’s post-test at P ,0.05 and
(**) two-tailed t-test P ,0.05. The results represent the means of
four independent experiments.
Neutrophil enhancement of P. aeruginosa biofilms
http://jmm.sgmjournals.org 497Fig. 5. Proteolytic degradation reduces the capacity of charged poly(amino acids) to disrupt neutrophil-induced P. aeruginosa
biofilms.(a) Whenpoly(amino acids)ofdifferingconcentrationwerecombined witha neutrophil-induced 24 h P.aeruginosabiofilm
in the presence of overnight culture material (OCM), there was no significant effect on biofilm disruption at 5 mM (open bars) or
10 mm (black bars). (b) Under identical conditions, when the capacity of (Asp)74 and (Asp)260 to disrupt biofilms was tested there
was not a significant effectinthe presenceofOCM.(c) When(Asp)260 (open bars)was combined witha proteaseinhibitor cocktail
(black bars) in the presence of the OCM, a significant disruption of the biofilm was achieved, which was further increased when the
protease inhibitor concentration was increased to sevenfold (crosshatched bars). (d) When the biofilms were removed from the
OCM and washed once in saline, (Asp)260 exhibited a significant disruptive effect (open bar). No enhancement was achieved by
theadditionofaproteaseinhibitorcocktail (blackbars)followingremovaloftheneutrophil cellularmilieu.All assaysareasmeasured
by absorbance from CV staining. Significance (*) was calculated by one-way ANOVA followed by Dunnett’s post-test at P ,0.05
and (**) two-tailed t-test P ,0.05. The results represent the means of three independent experiments.
Fig. 6. Neutrophil-induced P. aeruginosa biofilms are not disrupted by anti-pseudomonal antibiotics. Neutrophil-induced
PAO1 biofilms formed at a 1:0.01 ratio of bacteria to neutrophils were exposed to the antibiotics ciprofloxacin (a) or tobramycin
(b) for 3 h at 37 6C at concentrations ranging from 8 to 1024 mgm l
”1. The biofilm density was then quantified by CV staining.
No disruption of the biofilm was observed in response to either antibiotic over the range of dilutions tested. An untreated biofilm,
as well as a media-only control, were included to serve as a reference of biofilm formation and background staining. Both assays
are as measured by absorbance from CV staining. No significant differences were observed as calculated by the Kruskal–Wallis
test followed by Dunn’s multiple comparison test to the untreated biofilm at P ,0.05. The results represent the means of three
independent experiments.
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bacteria recovered from pooled wells was consistent, and
that neither (Asp)74 nor (Ser)74 displayed enhanced growth
or bactericidal properties (not shown). In addition, the
protease inhibitors pepstatin A, leupeptin and aprotinin
alone or in combination displayed no antimicrobial effect.
DNase disrupts P. aeruginosa biofilms, and
prevents their formation in the presence of
neutrophils
Previously, our group and others have shown the capacity
of DNase to disrupt P. aeruginosa biofilms (Frederiksen
et al., 2006; Walker et al., 2005; Whitchurch et al., 2002),
supporting the concept that DNA is also an essential
component of the ‘scaffolding’. Under the conditions used
in Fig. 4, exposure to DNase for 3 h disrupts 24-h-old
neutrophil-induced biofilms (Fig. 8a). Likewise, DNase was
able to significantly prevent biofilm formation in the
presence of neutrophils (Fig. 8b), under the conditions
described for Fig. 7. In contrast, RNase demonstrated no
capacity to disrupt (Fig. 8a) or prevent (Fig. 8b) biofilm
formation.
Poly(aspartic acid) works in conjunction with
DNase to disrupt biofilms
While concentrated DNase (Fig. 8a) or poly(aspartic acid)
(Fig. 4) are both capable of disrupting an early biofilm over
the course of a 3 h exposure, during DNase therapy in the
CF airway it is likely that biofilms are exposed to DNase
over a wide range of concentrations, and the effective
duration of exposure may be quite brief. Furthermore, in
the setting of chronic infections, biofilms are likely more
than 24 h old. We tested the capacity of DNase and
(Asp)260 to disrupt biofilms when administered over a
shorter period, at lower concentrations, and with thicker
and more mature biofilms.
When the duration of exposure to DNase was reduced to
only 10 min, a 24-h-old neutrophil-induced biofilm was
still reduced by 75% (Fig. 9a). However, a biofilm grown
for 48 h was reduced by only 42% by 10 min of DNase
treatment (Fig. 9b). Likewise, biofilms at later stages of
growth (48 h) also had greater resistance to disruption
with (Asp)260 and DNase; however, in combination these
agents were effective in disrupting biofilms (P ,0.01).
Exposing a 24 h neutrophil-induced biofilm for only
10 min to (Asp)260 resulted in a 49% reduction in biofilm
density (Fig. 9a). When DNase was used in combination
with (Asp)260, the mixture resulted in an 82% reduction
(Fig. 9a). (Asp)260 alone could not reduce the density of a
more mature 48 h biofilm, but when used in conjunction
with DNase, (Asp)260 was able to reduce the biofilm by
78% (Fig. 8b).
The combined effect of (Asp)260 with DNase was dose-
dependent (Fig. 9c). By decreasing DNase concentration
fourfold (8.25 mg DNase ml
21), only a 16% decrease in the
biofilm density of a 48 h biofilm was achieved after 10 min
treatment (Fig. 9c), compared to 42% at the 33 mg DNase
ml
21 concentration (Fig. 9b). When the lower concentra-
tion of DNase was used in combination with (Asp)260, the
density of the biofilm was reduced by 67% (Fig. 9c),
demonstrating a strong synergistic effect between the
Fig. 7. Negative poly(amino acid) chains possess capacity to
prevent neutrophil-induced enhancement of P. aeruginosa biofilm
formation. Short-chain (Asp)74 and (Ser)74 at 10 mM were added
at time 0 to P. aeruginosa PAO1 combined with neutrophils
(1:0.01 ratio). Following 24 h incubation at 37 6C, anionic
(Asp)74 prevented biofilm formation while neutral (Ser)74 displayed
no effect. Assays are as measured by absorbance from CV
staining. Significance (*) was calculated by one-way ANOVA
followed by Dunnett’s post-test at P ,0.05 and two-tailed
t-test P ,0.05. The results represent the mean of three
independent experiments.
Fig. 8. Neutrophil-induced P. aeruginosa biofilms are both
disrupted and prevented by DNase. (a) P. aeruginosa strain
PAO1 biofilms were grown for 24 h in the presence of neutrophils
(1:0.01 ratio). The biofilms were then exposed to either DNase
(open bars) or RNase (black bars) for 3 h. The neutrophil-induced
biofilm was significantly disrupted by DNase, but not by RNase. (b)
DNase or RNase was combined with P. aeruginosa strain PAO1
and neutrophils (1:0.01 ratio), and a biofilm was allowed to form
for 24 h. The presence of DNase prevented the formation of the
biofilm, while RNase had no effect. Assays are as measured by
absorbance from CV staining. Significance (*) was calculated by
one-way ANOVA followed by Dunnett’s post-test at P ,0.05. The
results represent the means of three independent experiments.
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which DNase as a single agent has little effect, the presence
of (Asp)260 significantly enhances the capacity of DNase to
disrupt a biofilm formed in the presence of neutrophils.
Parallel experiments were conducted with the early and late
CF strains. Neutrophil-induced biofilms of the early CF
strain (24 h of growth) were not disrupted by a 10 min
exposure to DNase (Supplementary Fig. S6a), while the
late CF strain demonstrated a modest disruption (Supple-
mentary Fig. S6c). However, for both strains, the effect
of DNase was significantly increased by the addition of
(Asp)260 (Supplementary Fig. S6a, c). The synergistic effect
of DNase and (Asp)260 was also apparent following 48 h of
biofilm growth for both the early and late CF strains
(Supplementary Fig. S6b, d). Perhaps of greatest clinical
interest were attempts to disrupt the mucoid late CF strain
that had been allowed to form for 48 h in the presence
of neutrophils (Supplementary Fig. S6d). Under these
conditions, only the combination of DNase and (Asp)260
achieved significant disruption of the biofilm (Supple-
mentary Fig. S6d).
The markedly decreased DNase effect in the context of the
treatment of thicker 48 h biofilms, or with a mucoid strain
of P. aeruginosa recovered later in CF infection, likely
reflects an increased polysaccharide concentration that may
obscure DNA cleavage sites. However, the synergistic effect
of DNase with poly(aspartic acid) may stem from the
capacity of poly(aspartic acid) to sequester histones as well
as disassociating F-actin along with associated bacteria and
saccharides, allowing DNase exposure to a greater number
of sites for cleavage in the actin–DNA polymer.
The CF airway is particularly vulnerable to P. aeruginosa
infection, where these bacteria are able to survive
indefinitely in the presence of an exuberant recruitment
of neutrophils. Necrosis of the short-lived neutrophil
occurs consistently and rapidly, while clearance of the
cellular debris is ineffective, resulting in the enrichment of
already viscous mucus with both DNA and F-actin
(Lethem et al., 1990; Rubin, 2007; Sheils et al., 1996).
Additional DNA of bacterial origin is present in the CF
airway as well (Lethem et al., 1990). The production of a
P. aeruginosa biofilm is based on the association of the
bacteria with a matrix, either self-produced or exogenously
provided (Costerton et al., 1999; Hentzer et al., 2001;
Sriramulu et al., 2005). In humans, focal infection by P.
aeruginosa, and subsequent biofilm formation, always
Fig. 9. Poly(aspartic acid) works in cooperation with DNase to
disrupt neutrophil-induced P. aeruginosa biofilms. PAO1 biofilms
were allowed to form for 24 or 48 h in the presence of neutrophils
at a 1:0.01 ratio of bacteria to neutrophils. The biofilms were then
washed in saline and exposed to either poly(aspartic acid) alone
(open bars) or combined with DNase (black bars). In all experi-
ments, exposure to DNase and/or poly(aspartic acid) was for
10 min at 37 6C in saline. (a) As single agents, (Asp)260 (5 mM)
and 33 mg DNase ml
”1 effectively disrupted 24-h-old biofilms. (b)
Using a 48 h biofilm, 33 mg DNase ml
”1, but not (Asp)260 (5 mM),
was effective as a single agent. However, a significant increase in
biofilm disruption was achieved when (Asp)260 was combined with
DNase. (c) Using a 48 h biofilm and a lower concentration of
8.25 mg DNase ml
”1, a synergistic effect of (Asp)260 (5 mM) and
DNase was achieved. Assay is as measured by absorbance from
CV staining. Significance (*) was calculated by one-way ANOVA
followed by Dunnett’s post-test at P ,0.05 and (**) two-tailed t-
test P ,0.05. The results represent the means of three
independent experiments.
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response. P. aeruginosa infection of wounds, burns or the
cornea of contact lens wearers occurs only after neutrophils
have accumulated at the site of injury. In the case of the CF
airway, the released chromosomal DNA with associated
histones and F-actin provide a ready framework for
Pseudomonas to occupy and proliferate. Strands of negatively
charged DNA polymerize with negatively charged F-actin
filaments by interaction with positively charged species such
as histones and cations. P. aeruginosa associates in turn with
this structure by binding either DNA or F-actin (van Schaik
et al., 2005; Walker et al.,2 0 0 5 ) .
The presence of a framework of neutrophil DNA and
F-actin may help to explain the efficacy of inhaled DNase
in CF, which is associated with a decrease in infectious
burden or frequency of pulmonary exacerbations
(Frederiksen et al., 2006; Robinson, 2002). While improved
sputum clearance is generally beneficial in controlling CF
airway infection, the potential of DNase may be more fully
realized by the addition of anionic polymers to disrupt
biofilms in vivo. We have demonstrated that the presence
of abundant F-actin and DNA in a neutrophil-rich
environment is exploited by P. aeruginosa to ensure
survival via biofilm development. Thus accounting for
the incorporation of neutrophil products into the med-
ically relevant P. aeruginosa biofilm is a logical advance-
ment in our understanding of this extraordinary pathogen.
It is conceivable that strategies to disrupt F-actin, as an
adjunct to treatment with DNase and antibiotics, will
represent an incremental improvement in our approach to
treating chronic P. aeruginosa infection in the CF airway.
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